Sign in
4

Changes in Ownership

BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001144204-05-009931

Options or other derivatives

  • Chief Financial Officer acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STOLICK DAVID · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2005-03-29 Grant or award : show line 1 in the form Stock Option (right to buy) +400,000 $0.75 2015-02-13 400,000 400,000 D
Loading xslF345X02/v015555_ex.xml…